Review
Aug 2026
IFI44L promoter hypomethylation as an epigenetic biomarker of systemic lupus erythematosus: A systematic review and meta-analysis.
IFI44L promoter hypomethylation represents a significant and reproducible epigenetic signature of SLE across populations and study designs and its diagnostic performance remains consistent, supporting IFI44L methylation as a promising biomarker for SLE.
Kainat Sheraz, Aasiyah Fagbo, Rahemeen Siddique et al.
· Lupus · 0 citations